| abstract |
The present invention relates to an anti-adhesion agent for preventing adhesion between surgical tissues, 1.0 to 15% by weight of alginic acid, 0 to 2.5% by weight of polyethylene glycol (PEG), 0 to 8% by weight of agarose, and 0 to antibiotics. 1 wt% and 73.5-99.9 wt% of water. The present invention can effectively prevent adhesion between the surgical site or bleeding site and the existing tissue site after the closure of the surgical site is completed, hemostatic effect, anti-inflammatory effect, adhesion and coating effect is also excellent. The anti-adhesion agent of the present invention is very excellent in transparency, adhesion, affinity and flowability. |